Tricaine mesylate
Anesthetic used in veterinary medicine
Overview[edit]

Tricaine mesylate, also known as MS-222, is a commonly used anesthetic agent in veterinary medicine, particularly for aquatic animals. It is a white, crystalline powder that is soluble in water and is used to induce anesthesia in fish and amphibians.
Chemical Properties[edit]
Tricaine mesylate is chemically known as ethyl 3-aminobenzoate methanesulfonate. It is a derivative of benzocaine, a local anesthetic. The chemical structure of tricaine mesylate allows it to be effective in aquatic environments, where it is used to sedate or anesthetize animals for various procedures.
Mechanism of Action[edit]
Tricaine mesylate works by blocking sodium channels in the neurons, which inhibits the propagation of action potentials. This action results in a reversible loss of sensation and consciousness in the animal. The anesthetic effect is dose-dependent, and careful monitoring is required to ensure the safety of the animal.
Usage in Veterinary Medicine[edit]
Tricaine mesylate is primarily used in the aquaculture industry and in research settings. It is used to anesthetize fish for surgery, tagging, and other procedures that require the animal to be immobilized. The drug is typically administered by dissolving it in water, where the fish or amphibian is then immersed until the desired level of anesthesia is achieved.
Safety and Handling[edit]

While tricaine mesylate is generally considered safe when used properly, it is important to handle it with care. Overdose can lead to prolonged recovery times or even mortality in sensitive species. It is also important to note that tricaine mesylate is not approved for use in animals intended for human consumption in some regions.
Environmental Impact[edit]
The use of tricaine mesylate in aquatic environments requires consideration of its potential environmental impact. Proper disposal and management of the anesthetic solution are necessary to prevent contamination of natural water bodies.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian